Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Tff Pharmaceuticals Inc
TFFPCurrent price
0.065 USD
0 USD (0.00%)
Last closed
0.065 USD
Company
www.tffpharma.com
ISIN
US87241J1043
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
288 798 USD
Yield for 12 month
-99.14 %
1Y
3Y
5Y
10Y
15Y
TFFP
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment and prophylaxis of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It also develops other dry powder products, such as Augmenta human derived monoclonal antibodies for the treatment of COVID-19 disease; and other vaccines. It has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs. TFF Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Fort Worth, Texas. Address: 1751 River Run, Fort Worth, TX, United States, 76107
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
30.00 USDP/E ratio
–Dividend Yield
–Current Year
+733 871 USD
Last Year
–
Current Quarter
+193 387 USD
Last Quarter
+650 222 USD
Current Year
+231 391 USD
Last Year
-388 221 USD
Current Quarter
+193 387 USD
Last Quarter
+509 630 USD
Key Figures TFFP
1 year
3 years
5 years
10 years
EBITDA
-19 006 206 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-105.91 %
PEG Ratio
–
Return On Equity TTM
-213.51 %
Wall Street Target Price
30.00 USD
Revenue TTM
1 202 586 USD
Book Value
4.04 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
95.10 %
Dividend Yield
–
Gross Profit TTM
-21 212 704 USD
Earnings per share
-5.50 USD
Diluted Eps TTM
-5.50 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics TFFP
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History TFFP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:25
Payout Ratio
–
Last Split Date
19.12.2023
Stock Valuation TFFP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
7.88
Price Sales TTM
0.24
Enterprise Value EBITDA
-0.50
Price Book MRQ
0.092
Financials TFFP
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TFFP
For 52 weeks
0.061 USD
11.00 USD
50 Day MA
1.34 USD
Shares Short Prior Month
304 257
200 Day MA
2.59 USD
Short Ratio
1.77
Shares Short
157 155
Short Percent
5.02 %
BeatStart